Success Metrics

Clinical Success Rate
40.0%

Based on 2 completed trials

Completion Rate
40%(2/5)
Active Trials
1(14%)
Results Posted
100%(2 trials)
Terminated
3(43%)

Phase Distribution

Ph phase_2
2
29%
Ph phase_1
4
57%
Ph not_applicable
1
14%

Phase Distribution

4

Early Stage

2

Mid Stage

0

Late Stage

Phase Distribution7 total trials
Phase 1Safety & dosage
4(57.1%)
Phase 2Efficacy & side effects
2(28.6%)
N/ANon-phased studies
1(14.3%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

40.0%

2 of 5 finished

Non-Completion Rate

60.0%

3 ended early

Currently Active

1

trials recruiting

Total Trials

7

all time

Status Distribution
Active(1)
Completed(2)
Terminated(3)
Other(1)

Detailed Status

Terminated3
Completed2
Active, not recruiting1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
7
Active
1
Success Rate
40.0%
Most Advanced
Phase 2

Trials by Phase

Phase 14 (57.1%)
Phase 22 (28.6%)
N/A1 (14.3%)

Trials by Status

completed229%
active_not_recruiting114%
terminated343%
unknown114%

Recent Activity

1 active trials
Showing 5 of 7
active_not_recruitingphase_1

[18F]FLT PET/CT in Rb+ Metastatic Breast Cancer

NCT02608216
terminatedphase_1

[18F]Fluciclovine and [18F]FLT PET/CT Assessment of Primary High-Grade Brain Tumors

NCT03276676
terminatedphase_1

A Pilot Study of 18F-FLT in Pediatric Patients With Central Nervous System (CNS) Tumors

NCT00633958
terminatedphase_1

A Study to Demonstrate the Safety and Preliminary Efficacy of 18F-FLT in Patients With Solid Tumours or Lymphoma

NCT01065805
completedphase_2

Phase II Study of Fluorine-18 3'-Deoxy-3'-Fluorothymidine (F-18-FLT) in Invasive Breast Cancer

NCT00572728
View all 7 trials

Clinical Trials (7)

Showing 7 of 7 trials
NCT02608216Phase 1

[18F]FLT PET/CT in Rb+ Metastatic Breast Cancer

Active Not Recruiting
NCT03276676Phase 1

[18F]Fluciclovine and [18F]FLT PET/CT Assessment of Primary High-Grade Brain Tumors

Terminated
NCT00633958Phase 1

A Pilot Study of 18F-FLT in Pediatric Patients With Central Nervous System (CNS) Tumors

Terminated
NCT01065805Phase 1

A Study to Demonstrate the Safety and Preliminary Efficacy of 18F-FLT in Patients With Solid Tumours or Lymphoma

Terminated
NCT00572728Phase 2

Phase II Study of Fluorine-18 3'-Deoxy-3'-Fluorothymidine (F-18-FLT) in Invasive Breast Cancer

Completed
NCT01480583Phase 2

GRN1005 Alone or in Combination With Trastuzumab in Breast Cancer Patients With Brain Metastases

Completed
NCT01713049Not Applicable

18F-FLT PET for Suspicious Findings on Mammography and Breast Ultrasound

Unknown

All 7 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
7